Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.11 USD
−31.63 M USD
0.00 USD
About Belite Bio, Inc
Sector
CEO
Yue Hsin Lin
Headquarters
San Diego
Website
Founded
2018
FIGI
BBG016LJYT18
Belite Bio, Inc. is a biopharmaceutical company engaged in the research and development of drugs. Its focus is on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.